These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 34684252)
1. Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis. León-Buitimea A; Garza-Cervantes JA; Gallegos-Alvarado DY; Osorio-Concepción M; Morones-Ramírez JR Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684252 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of invasive fungal infection. Castón-Osorio JJ; Rivero A; Torre-Cisneros J Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332 [TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Moen MD; Lyseng-Williamson KA; Scott LJ Drugs; 2009; 69(3):361-92. PubMed ID: 19275278 [TBL] [Abstract][Full Text] [Related]
4. Fungal infections in the immunocompromised host. Hawkins C; Armstrong D Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935 [TBL] [Abstract][Full Text] [Related]
5. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus. Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869 [TBL] [Abstract][Full Text] [Related]
6. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). Lortholary O; Fernández-Ruiz M; Perfect JR J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667 [TBL] [Abstract][Full Text] [Related]
7. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent. Rybak JM; Marx KR; Nishimoto AT; Rogers PD Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096 [TBL] [Abstract][Full Text] [Related]
8. [FUNGUS DISEASES OF THE LUNGS]. BUSCHMANN O Fortschr Geb Rontgenstr Nuklearmed; 1963 Sep; 99():284-93. PubMed ID: 14098977 [No Abstract] [Full Text] [Related]
9. Antifungal prophylaxis during neutropenia and immunodeficiency. Lortholary O; Dupont B Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863 [TBL] [Abstract][Full Text] [Related]
10. Invasive mould infections in the ICU setting: complexities and solutions. Bassetti M; Bouza E J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466 [TBL] [Abstract][Full Text] [Related]
11. [ENDOMYCOSES FROM THE VIEWPOINTS OF HUMAN AND VETERINARY MEDICINE]. GEMEINHARDT H Dtsch Gesundheitsw; 1964 Feb; 19():350-8. PubMed ID: 14171957 [No Abstract] [Full Text] [Related]
16. [State of the art in invasive diseases by filamentous fungi]. Pemán J; Quindós G Rev Iberoam Micol; 2014; 31(4):213-8. PubMed ID: 25449676 [TBL] [Abstract][Full Text] [Related]
17. Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens. Friedman DZP; Schwartz IS J Fungi (Basel); 2019 Jul; 5(3):. PubMed ID: 31330862 [No Abstract] [Full Text] [Related]
18. Focus on fungal infections. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470 [TBL] [Abstract][Full Text] [Related]